LNWWM
ALNY icon

Laird Norton Wetherby Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$577K Buy
1,266
+40
+3% +$16.3K 0.02% 527
2025
Q2 		$400K Buy
+1,226
New +$339K 0.02% 641
2024
Q4 		$270K Sell
1,147
-204
-15% -$53.7K 0.01% 731
2024
Q3 		$372K Buy
1,351
+202
+18% +$52.6K 0.02% 658
2024
Q2 		$279K Sell
1,149
-297
-21% -$46.9K 0.01% 738
2024
Q1 		$216K Sell
1,446
-177
-11% -$29.5K 0.01% 860
2023
Q4 		$311K Buy
1,623
+326
+25% +$55.5K 0.02% 711
2023
Q3 		$230K Sell
1,297
-256
-16% -$48.8K 0.01% 774
2023
Q2 		$295K Buy
1,553
+191
+14% +$37.9K 0.02% 722
2023
Q1 		$273K Sell
1,362
-123
-8% -$25.9K 0.02% 739
2022
Q4 		$353K Sell
1,485
-202
-12% -$43.1K 0.02% 633
2022
Q3 		$338K Buy
+1,687
New +$322K 0.02% 616
2022
Q2 		– Sell
-1,313
Closed -$214K – 908
2022
Q1 		$214K Buy
1,313
+3
+0.2% +$457 0.01% 839
2021
Q4 		$222K Buy
1,310
+48
+4% +$8.92K 0.01% 822
2021
Q3 		$238K Buy
1,262
+51
+4% +$9.57K 0.01% 796
2021
Q2 		$205K Buy
+1,211
New +$177K 0.01% 863

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's ALNY Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management increased its Alnylam Pharmaceuticals (ALNY) stake by 3.3% in Q3 2025, buying an estimated $16.3K and bringing the position to 1,266 shares worth $577K. The position accounts for 0.02% of the portfolio, ranked #527.

Laird Norton Wetherby Wealth Management first reported a position in ALNY in Q2 2021 and has held it in 16 quarters since. 823 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 1,266 shares of Alnylam Pharmaceuticals worth $577K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management bought 40 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $16.3K.
  • Alnylam Pharmaceuticals made up 0.02% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #527 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 16 quarters since.
  • 823 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.